Bexarotene [bexaroten]
topical
11
- Terms
-
Targretin
-
3-methyl-TTNEB
4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid
LG69 compound
LGD 1069
LGD-1069
LGD1069
Targretin
Persistent link
https://www.medvik.cz/link/D000077610
Definition
A rexinoid (an RXR-binding ligand), tetrahydronaphthalene derivative and RETINOID X RECEPTOR antagonist that is used in the treatment of CUTANEOUS T-CELL LYMPHOMA.
- DUI
- D000077610 MeSH Browser
- CUI
- M0250478
- History note
- 2019 (1995)
- Public note
- 2019; BEXAROTENE was indexed under TETRAHYDRONAPHTHALENES 1995-2018
Allowable subheadings
- AD
- administration & dosage 2
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.455.426.559.847.638.960.446
Bunolol
D02.455.426.559.847.638.960.837
Tetralones
D04.615.638.960.446
Bunolol
D04.615.638.960.837
Tetralones
bexarotene-3-(hydroxymethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione ester Chemical MeSH Browser